Kimiharu Takamatsu
Overview
Explore the profile of Kimiharu Takamatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
173
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanatani S, Kreutzmann J, Li Y, West Z, Larsen L, Nikou D, et al.
Science
. 2024 Nov;
386(6724):907-915.
PMID: 39571016
Recent advances in RNA analysis have deepened our understanding of cellular states in biological tissues. However, a substantial gap remains in integrating RNA expression data with spatial context across organs,...
2.
Shojo K, Tanaka N, Murakami T, Anno T, Teranishi Y, Takamatsu K, et al.
Lab Invest
. 2024 Sep;
104(10):102131.
PMID: 39244158
Targeting novel inhibitory ligands beyond anti-PD-1 and PD-L1 and CTLA-4 therapies is essential for the next decade of the immunotherapy era. Agents for the B7 family molecules B7-H3, B7-H4, and...
3.
Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy
Fukumoto K, Kanatani S, Jaremko G, West Z, Li Y, Takamatsu K, et al.
JCI Insight
. 2024 Aug;
9(14).
PMID: 39133649
Upper tract urothelial carcinoma (UTUC) is a rare form of urothelial cancer with a high incidence of recurrence and a low survival rate. Almost two-thirds of UTUCs are invasive at...
4.
Kaneko Y, Masuda T, Takamatsu K, Mikami S, Nakamura K, Nishihara H, et al.
J Pathol Clin Res
. 2024 Jun;
10(4):e12388.
PMID: 38923836
Tumor structure is heterogeneous and complex, and it is difficult to obtain complete characteristics by two-dimensional analysis. The aim of this study was to visualize and characterize volumetric vascular information...
5.
Ezaki T, Hongo H, Takamatsu K, Tanaka N, Oya M
Res Rep Urol
. 2024 Jun;
16:123-129.
PMID: 38855129
Purpose: Contact laser vaporization of the prostate (CVP) for benign prostatic hyperplasia is a widely accepted and safe procedure for elderly patients because of its lower bleeding risks. However, CVP...
6.
Kamisawa K, Matsumoto K, Takeda T, Takamatsu K, Niwa N, Yasumizu Y, et al.
Asian J Endosc Surg
. 2024 Feb;
17(2):e13291.
PMID: 38355894
Introduction: To investigate the impact of prostatic shape observed on preoperative magnetic resonance imaging (MRI) on the difficulty of robot-assisted laparoscopic radical prostatectomy (RALP). Methods: We retrospectively reviewed the operative...
7.
Izawa M, Tanaka N, Murakami T, Anno T, Teranishi Y, Takamatsu K, et al.
Lab Invest
. 2023 Mar;
103(4):100040.
PMID: 36870289
The cutting edge of cancer immunotherapy extends to ecto-5'-nucleotidase (CD73), a cell membrane enzyme that targets the metabolism of extracellular adenosine. We herein focused on the expression of CD73 to...
8.
Anno T, Tanaka N, Takamatsu K, Hakozaki K, Kufukihara R, Baba Y, et al.
Cancer Immunol Immunother
. 2023 Jan;
72(6):1779-1788.
PMID: 36646952
The effects of the innate immune status on patients with clear cell renal cell carcinoma (ccRCC) currently remain unknown. We herein provided more extensive information about the inner landscape of...
9.
Kufukihara R, Tanaka N, Takamatsu K, Niwa N, Fukumoto K, Yasumizu Y, et al.
Br J Cancer
. 2022 Jun;
127(6):1133-1141.
PMID: 35764788
Background: Analysis of long noncoding RNA (lncRNA) localisation at both the tissue and subcellular levels can provide important insights into the cell types that are important for their function. Methods:...
10.
Masuda T, Tanaka N, Takamatsu K, Hakozaki K, Takahashi R, Anno T, et al.
J Immunother Cancer
. 2022 Mar;
10(3).
PMID: 35314433
Background: The aims of this study were (1) to clarify the impact of tertiary lymphoid structure (TLS) status on the outcome and immunogenomic profile of human clear cell renal cell...